SCHEMBL1949104

SCHEMBL1949104

CCCCC(C(=O)ON1C(=O)CC(S(=O)(=O)O)C1=O)c1cc(C(C)SSc2ccccn2)ccc1C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17267279 0.81
SCHEMBL3483237 0.81
SCHEMBL4370106 0.79 HSD17B10 (0.32)
SCHEMBL17161322 0.77 RGS12 (0.31)
SCHEMBL29427561 0.74 LMNA (0.31)
SCHEMBL2169209 0.74 LMNA (0.31)
SCHEMBL8077101 0.73 TAS1R3 (0.32)
SCHEMBL30179538 0.73 HDAC1 (0.39)
SCHEMBL29250477 0.73 LMNA (0.31)
SCHEMBL3476705 0.72 HSD17B10 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110137235-A1 ULTRASONIC CANCER THERAPY ACCELERATOR TOTO LTD. (JP) 2011-06-09 US disclosed
US-20060002924-A1 Conjugate of notch signalling pathway modulators and their use in medical treatment CELLDEX THERAPEUTICS LIMITED (GB) 2006-01-05 US disclosed
WO-2004060262-A2 MODULATORS OF NOTCH SIGNALLING FOR USE IN IMMUNOTHERPAPY LORANTIS LIMITED (GB) 2004-07-22 WO disclosed